financetom
Business
financetom
/
Business
/
Flutter Entertainment Bets Big In Brazil With $350M NSX Stake: Details
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Flutter Entertainment Bets Big In Brazil With $350M NSX Stake: Details
Sep 13, 2024 12:06 PM

Flutter Entertainment plc ( FLUT ) shares are trading at a lower premarket on Friday. The company disclosed the acquisition of an initial 56% stake in NSX Group for around $350 million.

NSX is a Brazilian operator with a portfolio of brands, including the flagship Betnacional sports betting and iGaming brand.

The transaction aligns with Flutter’s strategy to invest in leading positions in international markets, positioning it as a significant player in the rapidly growing Brazilian market.

As per the transaction agreement, Flutter will pay around $350 million in cash and contribute its existing Betfair Brazil business to acquire a 56% stake in the newly combined Flutter Brazil business.

Additionally, a mechanism will allow Flutter to increase its shareholding through reciprocal put/call arrangements in the fifth and tenth years following the completion date.

The transaction is subject to customary regulatory approvals and is expected to close by the second quarter of 2025.

On a standalone basis, NSX anticipates to generate approximately $256 million in revenue and $34 million in adjusted EBITDA in 2024.

The company expects revenue synergies to be realized by leveraging Flutter’s proprietary pricing and risk management capabilities to enhance NSX’s sportsbook offering, as well as sharing Flutter’s iGaming expertise and content to improve the iGaming experience.

Following the successful approach in other newly regulated markets like the U.S., the company aims to drive market share growth and establish future profitability through strategic customer investment.

This is expected to result in an adjusted EBITDA loss of approximately $90 million – $100 million for Flutter Brazil in 2025.

As of June 30, Flutter’s cash and cash equivalents stood at $3.2 billion.

Price Action: FLUT shares are down 0.68% at $218.01 premarket at the last check Friday.

Image via Shutterstock

Read Next:

DraftKings Wins In Week 1 NFL Season, App Moves Up Rankings: ‘A Good Weekend For The Sportsbooks’

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Aura Biosciences Insider Sold Shares Worth $300,839, According to a Recent SEC Filing
Aura Biosciences Insider Sold Shares Worth $300,839, According to a Recent SEC Filing
Oct 21, 2024
08:45 AM EDT, 10/21/2024 (MT Newswires) -- Elisabet de los Pinos, Director, President and Chief Executive Officer, on October 18, 2024, sold 24,992 shares in Aura Biosciences ( AURA ) for $300,839. Following the Form 4 filing with the SEC, Elisabet de los Pinos has control over a total of 461,259 shares of the company, with 329,847 shares held directly...
Sanofi Engages In Exclusive Talks With US Private Equity CD&R For Its Consumer Health Business
Sanofi Engages In Exclusive Talks With US Private Equity CD&R For Its Consumer Health Business
Oct 21, 2024
Sanofi SA ( SNY ) and private equity Clayton Dubilier & Rice (CD&R) have finally entered into exclusive negotiations to potentially sell and purchase a 50% controlling stake in Opella, Sanofi’s consumer health unit.   The new step in Opella’s journey paves the way for creating a standalone player in consumer healthcare while supporting Sanofi’s strategy and increased focus on innovative...
Regenxbio Reports 97% Reduction in Injection Need for Wet AMD; Shares Rise Pre-Bell
Regenxbio Reports 97% Reduction in Injection Need for Wet AMD; Shares Rise Pre-Bell
Oct 21, 2024
09:08 AM EDT, 10/21/2024 (MT Newswires) -- Regenxbio ( RGNX ) reported Monday a 97% reduction in anti-VEGF injections at nine months in a Phase II study of ABBV-RGX-314 for wet age-related macular degeneration, or AMD. In the subretinal treatment of the second eye, 78% of patients remained injection-free, the company said. Visual acuity and retinal thickness were maintained, with...
Nigeria blocks Shell's asset sale in the Niger Delta
Nigeria blocks Shell's asset sale in the Niger Delta
Oct 21, 2024
ABUJA, Oct 21 (Reuters) - Nigeria has blocked the sale of Shell's entire onshore and shallow-water oil and gas assets in the Niger Delta, the country's upstream regulator said on Monday, roughly 10 months after the deal was announced. In a speech at an event in the capital Abuja, Nigerian Upstream Petroleum Regulatory Commission (NUPRC) CEO Gbenga Komolafe said the...
Copyright 2023-2025 - www.financetom.com All Rights Reserved